News
and updatesVERDI researchers contribute to landmark Mpox study published in The Lancet
Researchers from the VERDI project, Vivi Maketa, Placide Mbala-Kingebeni and Hypolite Muhindo-Mavoko, from the University of Kinshasa, have contributed to a landmark study published in The Lancet. The article offers the most comprehensive clinical description to date...
European clinical research for preparedness gets a new tool: the Central Data Repository of studies targeting infectious diseases with epidemic and pandemic potential
Today marks the launch of the Central Data Repository (CDR), the online database designed to support research pandemic preparedness efforts across Europe. Managed by the Cohort Coordination Board as part of the EU-funded VERDI and CoMeCT projects, the CDR offers a...
In Memoriam: Angela Lupattelli
It is with profound sadness that we share the heartbreaking news of the passing of our dear colleague and friend Angela Lupattelli. Angela’s sudden departure is an immense loss to her family, friends, colleagues and the scientific community. Angela was a brilliant...
Gripiradar launched in Estonia: Tracking COVID-19 and flu through Citizen Science
The VERDI Consortium is excited to announce the launch of Gripiradar, a new platform designed to collect data from the public to monitor the spread of viral respiratory infections in Estonia, including flu and COVID-19. This data will contribute to a study providing...
EU takes the lead in the search for new mpox treatments
As the monkeypox virus continues to pose a threat to global health, EU-funded researchers are working together with international partners to manage the disease and protect the most vulnerable. This article originally appeared on Horizon: The EU Research &...
VERDI General Assembly 2024: Sustainability and Future Directions
Last week, the VERDI project team gathered in Tallinn, Estonia, and online for the 4th General Assembly. This year’s meeting, which brought together around 60 people from 30 partner institutions, centered on ensuring the project's sustainability and included updates...
VERDI poster wins “Best Poster” Award at ESPID 2024!
We are pleased to announce that the poster “SARS-CoV-2 Infection Incidence and Severity in Immunocompromised Children: A Population-Based Study in Italy and Norway” has received the Best Poster Award from the ESPID Committee for Research! The poster presented results...
On the far side of COVID-19: Penta’s commitment to research preparedness for emerging infections affecting children and pregnant people
The recent COVID-19 pandemic served as a stark reminder of the vulnerability of children and pregnant people to emerging infections. While the public health emergency may have concluded in mid-2023, the threat of future pandemics remains a looming concern. In this...
VERDI Consortium contributes to development of core outcome set for Long COVID in children
Results from an international consensus study, aimed at establishing a core outcome set for Long COVID in children and young people, have been published in the European Respiratory Journal. Members of the VERDI Consortium Claire Thorne, Maternal-Infant Working Group...
VERDI cohorts join CoMeCT, a new European project to boost clinical research preparedness for future infectious disease outbreaks
CoMeCT, short for Coordination Mechanism for Cohorts and Trials, is a new EU-funded project aiming to strengthen European preparedness and response capacity for future health emergencies. Over the next three years, CoMeCT will act as a coordination platform bringing...